CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Deutsche Bank 33rd Annual Health Care Conference on Tuesday, May 6, 2008, at 9:30 a.m. ET at the InterContinental Hotel in Boston, Mass.
